CLINICAL_TRIALS
trial_result
· 2015-04-13
Clinical Trial Update: Low-dose IL-2( Interleukin-2) Treatment in SLE [NA]
Summary
A completed clinical trial evaluating low-dose interleukin-2 therapy for systemic lupus erythematosus; results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking University People's Hospital | Conditions: Systemic Lupus Erythematosus | NA | Status: COMPLETED | Results posted: 2015-04-13